Response Genetics, Inc. Stock Nasdaq
Equities
US76123U1051
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
2016 | Response Genetics, Inc Bankruptcy Case Dismissed | CI |
2016 | Motion for Case Dismissal Filed for Response Genetics, Inc | CI |
Sales 2013 | 19.8M 27.05M | Sales 2014 | 16.72M 22.84M | Capitalization | 12.28M 16.78M |
---|---|---|---|---|---|
Net income 2013 | -8M -10.93M | Net income 2014 | -13M -17.76M | EV / Sales 2013 | 1.92 x |
Net cash position 2013 | 6.85M 9.37M | Net Debt 2014 | 7.45M 10.17M | EV / Sales 2014 | 1.18 x |
P/E ratio 2013 |
-4.84
x | P/E ratio 2014 |
-0.9
x | Employees | - |
Yield 2013 * |
-
| Yield 2014 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Kevin Roy Harris
DFI | Director of Finance/CFO | 55 | 12-08-19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Kevin Roy Harris
DFI | Director of Finance/CFO | 55 | 12-08-19 |
1st Jan change | Capi. | |
---|---|---|
+52.36% | 58.06B | |
-3.86% | 40.53B | |
+36.39% | 38.99B | |
-12.01% | 26.56B | |
+14.13% | 26.7B | |
-21.62% | 18.98B | |
+0.21% | 12.17B | |
+25.96% | 11.92B | |
+23.02% | 12B |